Pulmobiotics

About:

Pulmobiotics is a pre-clinical life sciences company.

Top Investors: Invivo Capital Partners

Description:

Pulmobiotics is a Barcelona, Spain-based pre-clinical life sciences company using synthetic biology to develop new treatments and vaccines for various types of lung diseases.

Total Funding Amount:

3.9M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Barcelona, Catalonia, Spain

Founded Date:

2020-01-01

Founders:

Lluis Serrano, Maria Lluch Senar

Number of Employees:

1-10

Last Funding Date:

2022-12-15

IPO Status:

Private

Industries: